相似文献
1
Evidence of a "clear and consistent threshold" for bladder and liver cancer in the large ED01 carcinogenicity study.
Toxicol Sci. 2003 Aug;74(2):485; author reply 485-6. doi: 10.1093/toxsci/kfg117. Epub 2003 May 2.
2
Thresholds of carcinogenicity in the ED01 study.
Toxicol Sci. 2003 Aug;74(2):486-7; author reply 487-8. doi: 10.1093/toxsci/kfg134.
3
The ED01 study: summary and conclusions.
J Environ Pathol Toxicol. 1980;3(3 Spec No):179-83.
4
Thresholds in carcinogenicity in ED01 study.
Toxicol Sci. 2003 Sep;75(1):224-5. doi: 10.1093/toxsci/kfg176.
5
Re-examination of the ED01 study. Overview.
Fundam Appl Toxicol. 1981 Jan-Feb;1(1):28-63.
6
Waddell's representation of the tumor incidence data of the ED01 study is strongly misleading.
Toxicol Sci. 2003 Sep;75(1):223; author reply 223-4. doi: 10.1093/toxsci/kfg160.
7
Thresholds of carcinogenicity in the ED01 study.
Toxicol Sci. 2003 Mar;72(1):158-63. doi: 10.1093/toxsci/kfg004.
8
Dose and time responses models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously.
J Environ Pathol Toxicol. 1980;3(3 Spec No):55-68.
9
Biological model of ED01 hepatocarcinogenesis.
Toxicol Appl Pharmacol. 1996 Sep;140(1):19-29. doi: 10.1006/taap.1996.0193.
10
Re-examination of the ED01 study--risk assessment using time.
Fundam Appl Toxicol. 1981 Jan-Feb;1(1):88-123.
引用本文的文献
1
Nonlinear cancer response at ultralow dose: a 40800-animal ED(001) tumor and biomarker study.
Chem Res Toxicol. 2009 Jul;22(7):1264-76. doi: 10.1021/tx9000754.
Zotero 插件